Pharma Aids Limited (DSE:PHARMAID)
 591.40
 +2.50 (0.42%)
  At close: Nov 3, 2025
Pharma Aids Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
 Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year  | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 | 
|---|---|---|---|---|---|---|---|
Period Ending  | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 | 
Cash & Equivalents     | 43 | 32.72 | 15.12 | 24.91 | 19.98 | 14.08 | Upgrade   | 
Cash & Short-Term Investments     | 43 | 32.72 | 15.12 | 24.91 | 19.98 | 14.08 | Upgrade   | 
Cash Growth     | -14.26% | 116.46% | -39.30% | 24.68% | 41.86% | 43.93% | Upgrade   | 
Accounts Receivable     | 145.03 | 129.58 | 127.1 | 123.51 | 127.23 | 136.39 | Upgrade   | 
Other Receivables     | 23.24 | 23.84 | 28.06 | 29.31 | 32.16 | 39.46 | Upgrade   | 
Receivables     | 168.28 | 153.43 | 155.16 | 152.82 | 159.4 | 175.85 | Upgrade   | 
Inventory     | 72.73 | 61.84 | 56.83 | 63.67 | 39.36 | 24.45 | Upgrade   | 
Prepaid Expenses     | 37.34 | 30.38 | 21.5 | 14.53 | 7.9 | 5.44 | Upgrade   | 
Other Current Assets     | 168.24 | 141.7 | 65.87 | 51.62 | 40.62 | 21.4 | Upgrade   | 
Total Current Assets     | 489.58 | 420.07 | 314.48 | 307.54 | 267.25 | 241.22 | Upgrade   | 
Property, Plant & Equipment     | 93.63 | 60.12 | 66.86 | 72.27 | 75.4 | 74.12 | Upgrade   | 
Total Assets     | 583.22 | 480.19 | 381.34 | 379.82 | 342.65 | 315.34 | Upgrade   | 
Accounts Payable     | 2.63 | 5.55 | 1.66 | 1.42 | 0.16 | 0.43 | Upgrade   | 
Accrued Expenses     | 47.02 | 38.23 | 29.72 | 32.13 | 23.69 | 23.35 | Upgrade   | 
Short-Term Debt     | 23.23 | 18.16 | 11.47 | 0.99 | 0.3 | 5.09 | Upgrade   | 
Current Income Taxes Payable     | 88.13 | 73.6 | 50.05 | 33.32 | 14.83 | 17.6 | Upgrade   | 
Other Current Liabilities     | 2.09 | 1.75 | 3.44 | 3.34 | 12.68 | 11.32 | Upgrade   | 
Total Current Liabilities     | 163.09 | 137.3 | 96.34 | 71.2 | 51.67 | 57.79 | Upgrade   | 
Long-Term Deferred Tax Liabilities     | 2.27 | 0.05 | 0.22 | 0.27 | - | - | Upgrade   | 
Other Long-Term Liabilities     | - | - | 0 | - | - | - | Upgrade   | 
Total Liabilities     | 165.37 | 137.35 | 96.56 | 71.47 | 51.67 | 57.79 | Upgrade   | 
Common Stock     | 31.2 | 31.2 | 31.2 | 31.2 | 31.2 | 31.2 | Upgrade   | 
Retained Earnings     | 350.84 | 310.42 | 253.58 | 275.56 | 257.09 | 223.43 | Upgrade   | 
Comprehensive Income & Other     | 35.81 | 1.23 | 0 | 1.59 | 2.69 | 2.92 | Upgrade   | 
Shareholders' Equity     | 417.85 | 342.85 | 284.78 | 308.35 | 290.98 | 257.56 | Upgrade   | 
Total Liabilities & Equity     | 583.22 | 480.19 | 381.34 | 379.82 | 342.65 | 315.34 | Upgrade   | 
Total Debt     | 23.23 | 18.16 | 11.47 | 0.99 | 0.3 | 5.09 | Upgrade   | 
Net Cash (Debt)     | 19.77 | 14.56 | 3.64 | 23.92 | 19.67 | 9 | Upgrade   | 
Net Cash Growth     | -57.27% | 299.66% | -84.77% | 21.59% | 118.67% | - | Upgrade   | 
Net Cash Per Share     | 6.34 | 4.67 | 1.17 | 7.67 | 6.31 | 2.88 | Upgrade   | 
Filing Date Shares Outstanding     | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | Upgrade   | 
Total Common Shares Outstanding     | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | 3.12 | Upgrade   | 
Working Capital     | 326.49 | 282.77 | 218.14 | 236.35 | 215.59 | 183.44 | Upgrade   | 
Book Value Per Share     | 133.93 | 109.89 | 91.28 | 98.83 | 93.26 | 82.55 | Upgrade   | 
Tangible Book Value     | 417.85 | 342.85 | 284.78 | 308.35 | 290.98 | 257.56 | Upgrade   | 
Tangible Book Value Per Share     | 133.93 | 109.89 | 91.28 | 98.83 | 93.26 | 82.55 | Upgrade   | 
Land     | 36 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | Upgrade   | 
Buildings     | 14.57 | 14.29 | 14.29 | 14.29 | 12.57 | 12.21 | Upgrade   | 
Machinery     | 195.42 | 193.89 | 193.79 | 191.74 | 188.76 | 180.06 | Upgrade   | 
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.